Compass Therapeutics Inc [CMPX] stock prices are up 4.76% to $1.32 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CMPX shares have gain 10.92% over the last week, with a monthly amount glided 22.22%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Compass Therapeutics Inc [NASDAQ: CMPX] stock has seen the most recent analyst activity on January 31, 2023, when Jefferies initiated its Buy rating and assigned the stock a price target of $8. Previously, Stifel started tracking the stock with Buy rating on January 27, 2023, and set its price target to $9. Ladenburg Thalmann started tracking the stock assigning a Buy rating and suggested a price target of $7 on March 15, 2022. B. Riley Securities initiated its recommendation with a Buy and recommended $10 as its price target on January 19, 2022. Raymond James started tracking with a Outperform rating for this stock on December 22, 2021, and assigned it a price target of $5. In a note dated December 20, 2021, SVB Leerink initiated an Outperform rating and provided a target price of $12 on this stock.
The stock price of Compass Therapeutics Inc [CMPX] has been fluctuating between $0.76 and $2.57 over the past year. Compass Therapeutics Inc [NASDAQ: CMPX] shares were valued at $1.32 at the most recent close of the market.
Analyzing the CMPX fundamentals
Gross Profit Margin for this corporation currently stands at 0.34% with Operating Profit Margin at -18.79%, Pretax Profit Margin comes in at -15.98%, and Net Profit Margin reading is -15.98%. To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -0.29 and Total Capital is -0.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.2367 points at the first support level, and at 1.1533 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3667, and for the 2nd resistance point, it is at 1.4133.
Ratios To Look Out For
It’s worth pointing out that Compass Therapeutics Inc [NASDAQ:CMPX]’s Current Ratio is 16.15. In addition, the Quick Ratio stands at 16.15 and the Cash Ratio stands at 6.08. Considering the valuation of this stock, the price to sales ratio is 213.67, the price to book ratio is 1.24.
